ArticleCancer research2015
The cyclic AMP pathway is a sex-specific modifier of glioma risk in type I neurofibromatosis patients.
Nicole M Warrington et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
44 papers cite it
this papercites it